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Histopathological assessment of salivary gland biopsies is an 
important element of the diagnostic workup of Sjögren's syn-
drome (SS) (Fox, 2017; Kroese, Haacke, & Bombardieri, 2018). 
Microscopic evaluation of salivary glands of primary SS (pSS) 
patients reveals characteristic periductal lymphocytic infiltrates 
(foci), which mainly consist of T and B lymphocytes, as well as a 
variety of non-lymphoid cells, including dendritic cells and mac-
rophages. Over time, these infiltrates may become organised to 
ectopic lymphoid tissue with T/B cell compartmentalisation, pres-
ence of CD21+ follicular dendritic cell (FDC) networks and high 
endothelial venules (Fisher et al., 2017; Kroese et al., 2014, 2018; 
Salomonsson et al., 2003). Germinal centres (GCs) are present 
within this ectopic lymphoid tissue in roughly one-quarter of the 
salivary gland biopsies of pSS patients and their presence is as-
sociated with more severe disease compared to GC-negative pSS 
patients (Risselada, Looije, Kruize, Bijlsma, & Roon, 2013). These 
glandular ectopic GCs express mRNA encoding for activation-in-
duced deaminase, an enzyme critical for the induction of somatic 
hypermutation and essential for the main function of GCs, the 
generation of high-affinity memory B cells (Bombardieri et al., 
2007; Le Pottier et al., 2009; Muramatsu et al., 2000).
Presence of GCs in biopsies taken for the diagnosis of pSS has 
been suggested to be a risk factor for lymphoma development 
(Nishishinya et al., 2015; Sène et al., 2018; Theander et al., 2011), a 
finding recently disputed by us (Haacke et al., 2017, 2019). Detection 
of GCs in routine haematoxylin and eosin (H&E)-stained sections can 
be challenging because small GCs may be overlooked and distinction 
between GCs and lymphoepithelial lesions may be difficult (Fisher 
et al., 2017; Haacke et al., 2018). Therefore, immunohistochemical 
identification using antibodies directed against CD21, expressed 
by FDCs (but also by B cells) or Bcl6, a transcription factor highly 
expressed by GC-B cells, has been used (Bombardieri et al., 2007; 
Carubbi et al., 2019; Haacke et al., 2017), but consensus criteria re-
garding identification of GCs are lacking (Haacke et al., 2018). Hence, 
the aim of this study was to asses which staining is most suitable to 
unequivocally identify GCs in diagnostic salivary gland biopsies of 
pSS patients by comparing H&E, CD21 and Bcl6 stainings.
In our study, we restricted ourselves to these three markers, 
which can be easily applied in an automated fashion in diagnostic 
pathology laboratories. For this reason, we did not consider staining 
for other GC-associated markers, such as activation-induced deam-
inase, as potential candidates for identification of GCs in biopsies.
From 42 pSS patients, classified according to American College 
of Rheumatology (ACR)-European League Against Rheumatism 
(EULAR) classification criteria (Shiboski et al., 2017), both a labial 
salivary gland and a parotid salivary gland biopsy were obtained (see 
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Table 1). Four-micrometre-thick serial sections of salivary gland bi-
opsies were stained with H&E and immunohistochemically for CD21 
and Bcl6. For detailed ethical approval information, staining charac-
teristics and statistical analysis see Appendix S1.
In H&E-stained sections, a GC was defined as a clearly visible 
lighter area in a lymphocytic infiltrate containing centrocytes, centro-
blasts, FDCs and macrophages. In CD21-stained sections, a network 
of positive staining within a focus was classified as a FDC network. In 
Bcl6-stained sections, a cluster of ≥5 adjacent positive cells within a 
focus was classified as a GC (Haacke et al., 2017). Even though Bcl6 
is also expressed by follicular helper T cells, this expression does not 
interfere with detection of GCs as these cells are not organised in clus-
ters as GCs, but lie scattered throughout the tissue (Figure 1).
Six labial and eleven parotid salivary gland biopsies did not 
contain any H&E-defined periductal foci. For the remaining biop-
sies, 36 labial and 31 parotid glands, all individual H&E-defined 
foci (210 labial and 141 parotid glands) were analysed on serial 
sections. This staining revealed that 1% (3/210) of labial gland 
foci and 6% (9/141) of parotid gland foci contained H&E-defined 
GCs. Immunohistochemical staining for CD21 revealed that 24% 
(50/210) of the foci in the labial gland and 49% (69/141) of the 
foci in the parotid gland contained CD21+FDC networks (Table 2). 
Importantly, after staining for Bcl6, we showed that only 18% (9/50) 
of the labial gland foci with CD21+FDC networks and 32% (22/69) 
of the parotid gland foci with CD21+FDC networks also comprised 
Bcl6+GCs. Apparently, not all foci contain CD21+FDC networks 
and not all foci with CD21+FDC networks also harbour Bcl6+GCs. 
This was confirmed by dual CD21/Bcl6 staining (Figure 1a). 
Consequently, the number of CD21+FDC networks/mm2 was sig-
nificantly higher than the number of H&E+- and Bcl6+-defined 
GCs/mm2 in both labial and parotid salivary glands (Figure 1b and 
c). We observed a significant correlation between CD21+FDC net-
works/mm2 in parotid and labial salivary gland biopsies (Figure 1d, 
r = .60, p = .001), indicating comparability in lymphoid organisation 
at these two anatomical sites. Such a correlation was not seen for 
the presence of H&E- or Bcl6-defined GCs.
In a recent study, Carubbi et al. analysed the usage of CD3/
CD20 as well as CD21 and Bcl6 as markers for the detection of 
GCs (Carubbi et al., 2019). While they conclude that combination 
of CD3/CD20 and CD21 should be recommended for assessment 
of GCs, we clearly show here that usage of CD21 as surrogate 
marker for GCs significantly overestimates GC counts. The rea-
son for this is that formation of B-cell follicles and presence of 
CD21+FDC networks (which are also present in primary B-cell fol-
licles) do not also imply presence of GCs (MacLennan, 1994). On 
the other hand, staining with H&E revealed fewer GCs compared 
to staining for Bcl6, most likely because small GCs can easily be 
overlooked on H&E.
Although staining for CD21 is thus less appropriate for detection 
of GCs, staining for CD21 is still valuable. FDCs play an essential role 
in the spatial orientation and B/T-cell compartmentalisation in ectopic 
lymphoid tissues due to their CXCL13 producing property. Presence of 
FDC networks suggests a more advanced stage of ectopic lymphoid 
development and may therefore be a useful marker for classification of 
the organisation of glandular tissue (Jonsson & Skarstein, 2008).
In conclusion, we propose to use Bcl6 as a simple, sensitive and 
specific marker for unequivocal identification of GCs in salivary gland 
biopsies of (suspected) pSS patients. Large prospective studies are 
now needed to evaluate whether presence of GCs in diagnostic sali-
vary gland biopsies for pSS is a risk factor for non-Hodgkin lymphomas 
or not, and whether it can be used for stratification of pSS patients for 
personalised medicine (Delli et al., 2019; Kroese et al., 2018).
TA B L E  1   Demographic, clinical and histological parameters of 
patients with primary Sjögren's syndrome
 
pSS patients 
(n = 42)
Demographic characteristics
Age, years 52 ± 13
Female, n (%) 41 (97.6)
Caucasian, n (%) 41 (97.6)
Serological parameters
RF positive, n (%) 25 (59.5)
ANA positive, n (%) 10 (23.8)
Anti-SSA positive, n (%) 32 (76.2)
Anti-SSB positive, n (%) 15 (35.7)
IgG 15.4 [11.7–19.4]
ESR 23.0 [9.8–45.5]
CRP 2.8 [1.0–5.5]
Clinical parameters
ESSDAI score 3.5 [2.0–9.0]
Schirmer, mm/5 min 2.5 [0.0–5.0]
UWS, ml/min 0.1 [0.0–0.2]
Histopathological parameters of the labial gland
Focus score 1.3 [1.0–2.4]
≤70% IgA plasma cells, n (%) 19 (45.2)
Lymphoepithelial lesions, n (%) 16 (38.1)
Relative area of CD45+ infiltrate* 9.1 [6.1–19.8]
Histopathological parameters of the parotid gland
Focus score 1.0 [0.0–1.7]
≤70% IgA plasma cells, n (%) 12 (28.6)
Lymphoepithelial lesions, n (%) 18 (42.9)
Relative area of CD45+ infiltrate* 4.5 [1.4–17.0]
Note: Patients were classified according to the ACR-EULAR criteria. 
Data are represented as mean ± SD, median [95% CI] or number (%).
Abbreviations: ANA, antinuclear antibodies; CRP, C-reactive protein; 
ESR, erythrocyte sedimentation rate; ESSDAI, European League 
Against Rheumatism SS Disease Activity Index; n, number of patients; 
pSS, primary Sjögren's syndrome; RF, rheumatoid factor; SSA, Sjögren's 
syndrome antigen A; SSB, Sjögren's syndrome antigen B; UWS, 
unstimulated whole saliva.
*% of area of lymphocytic infiltrate in salivary gland parenchyma 
(Aperio ImageScope v12.0). 
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